Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04694638 · ClinicalTrials.gov registry record · NA
Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04694638: Completed NA study, sponsored by Mayo Clinic.
NCT04694638 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04694638, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.
Interventions
- OTHER Body position change
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-05-21 |
| Est. Completion | 2023-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04694638
The ClinicalTrials.gov registry entry for NCT04694638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Body position change is the first listed.
NCT04694638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04694638 about?
NCT04694638 is a clinical study titled "Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection". This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.
What is the current status of trial NCT04694638?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-05-21. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT04694638?
The interventions under investigation include: Body position change (OTHER).
Who is sponsoring clinical trial NCT04694638?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.